Li Min, Zang Wenqiao, Wang Yuanyuan, Li Yuebai, Ma Yunyun, Wang Na, Tang Yue, Liu Lulu, Dong Ziming, Zhao Guoqiang
College of Basic Medical Sciences, Zhengzhou University, No. 100, Kexue Road, Zhengzhou, 450001, China.
Tumour Biol. 2013 Oct;34(5):3259-63. doi: 10.1007/s13277-013-0898-5. Epub 2013 Jun 8.
The present study analyzed the correlation of DNA polymerase β (DNA polβ) promoter mutations and activity in esophageal squamous cell carcinoma (ESCC). The DNA polβ promoter was amplified from 108 ESCC samples and adjacent paracancerous samples by PCR and cloned into the pGL3-enhancer luciferase vector. The recombined vectors were transfected into esophageal carcinoma cells (EC9706, Eca109, and KYSE30), and luciferase activity was detected using dual luciferase reporter gene technology. Eleven polβ promoter mutations were identified and submitted to GenBank. The mutation rate of the DNA polβ promoter was higher in ESCC tissues (36/108, 33.3 %) than in the paired paracancerous tissues (21/108, 19.4 %) (P = 0.021). The C → A mutation at locus -37 was the hotspot mutation in cancerous tissues, and its frequency was higher in ESCC tissues (26/108) than in paracancerous tissues (7/108) (P = 0.00). The highest relative luciferase activity (RLA) was observed in the DNA polβ promoter, with a C → A mutation at -37. Significant differences in RLA were observed between mutant DNA polβ promoters (except for C detected at -19, T → C at -194, C → A at -37, and T → C at 30) and the wild-type DNA polβ promoter (P = 0.000), and RLA was significantly higher in ESCC tissues than in paracancerous tissues (P = 0.003). Our findings suggest that the upregulation of transcriptional activity induced by mutations in the DNA polβ promoter in ESCC tissues may be one of the molecular mechanisms mediating abnormal overexpression of DNA polβ in ESCC.
本研究分析了食管鳞状细胞癌(ESCC)中DNA聚合酶β(DNA polβ)启动子突变与活性的相关性。通过PCR从108例ESCC样本及其癌旁组织样本中扩增DNA polβ启动子,并将其克隆到pGL3增强型荧光素酶载体中。将重组载体转染到食管癌细胞(EC9706、Eca109和KYSE30)中,使用双荧光素酶报告基因技术检测荧光素酶活性。鉴定出11个polβ启动子突变并提交至GenBank。ESCC组织中DNA polβ启动子的突变率(36/108,33.3%)高于配对的癌旁组织(21/108,19.4%)(P = 0.021)。-37位点的C→A突变是癌组织中的热点突变,其在ESCC组织中的频率(26/108)高于癌旁组织(7/108)(P = 0.00)。在DNA polβ启动子中观察到最高的相对荧光素酶活性(RLA),其中-37位点存在C→A突变。在突变的DNA polβ启动子(除了在-19检测到的C、-194的T→C、-37的C→A和30的T→C)与野生型DNA polβ启动子之间观察到RLA有显著差异(P = 0.000),并且ESCC组织中的RLA显著高于癌旁组织(P = 0.003)。我们的研究结果表明,ESCC组织中DNA polβ启动子突变诱导的转录活性上调可能是介导ESCC中DNA polβ异常过表达的分子机制之一。